• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Exact Sciences posts positive data on Cologuard 2.0 ahead of readouts on rival tests

cafead

Administrator
Staff member
  • cafead   Jan 20, 2022 at 11:22: AM
via Exact Sciences has released results from a study of the updated Cologuard test it is developing to cement its position in the colorectal cancer screening market. The study, which Exact Sciences designed to mimic its ongoing pivotal trial, found Cologuard 2.0 has a lower false positive rate than the current product and is better at detecting precancerous lesions.

article source
 

<